BTAI CIK: 1720893

BioXcel Therapeutics, Inc.

  • United States
  • Healthcare
  • Drug Manufacturers - Specialty & Generic
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
0.36
FY23:
0.12
FY24:
0.12
FY25:
0.48
(positive)
Change from FY21 to FY25
millions USD
FY21:
−107
FY22:
−160
FY23:
−172
FY24:
−67.2
FY25:
−50.5
(positive)
millions USD
FY21:
–
FY22:
−157
FY23:
–
FY24:
–
FY25:
–
(positive)
millions USD
FY21:
–
FY22:
−166
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−107
FY22:
−166
FY23:
−179
FY24:
−59.6
FY25:
−69.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data